Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
Completed · Phase 2
Conditions studied: Leukemia, Acute Disease, Acute Myeloid Leukemia, Nonlymphocytic Leukemia, Myelodysplastic Syndromes
In brief
This study will evaluate the overall remission rate of treatment with vosaroxin (formerly voreloxin) Injection in patients at least 60 years of age with previously untreated AML
Key facts
- Study ID
- NCT00607997
- Run by
- Sunesis Pharmaceuticals
- People needed
- 113
- Starts
- 2008-05-15
- Expected to finish
- 2009-11-23
- Last updated by the study team
- 2017-06-28
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Hospital — Phoenix, Arizona, United States
- Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
- Scripps Cancer Center — La Jolla, California, United States
- Rocky Mountain Blood and Marrow Transplant Program — Denver, Colorado, United States
- Rush University Medical Center — Chicago, Illinois, United States
- The University of Chicago — Chicago, Illinois, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- St. Francis Hospital & Health Systems at Beech Grove Campus — Indianapolis, Indiana, United States
- Cancer Center of Kansas — Wichita, Kansas, United States
- Cancer Center of Kansas — Wichita, Kansas, United States
- LSU Health Sciences Center at Shreveport — Shreveport, Louisiana, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- University of Mississippi Medical Center — Jackson, Mississippi, United States
- University of MO Ellis Fischel Cancer Center — Columbia, Missouri, United States
- University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
- Hollings Cancer Center at Medical University of South Carolina — Charleston, South Carolina, United States
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Huntsman Cancer Institute at the University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.